Nashville-based Optura closed a $17.5 million Series A in June 2026, led by Salesforce Ventures with participation from Echo Health Ventures and continued backing from Susa Ventures, Matrix Partners, and HC9 Ventures. The round brings Optura's total funding to $25 million.
Optura's platform is built around a straightforward but increasingly important idea in enterprise healthcare AI: proving return on AI investment, not just deploying AI tools and hoping the value shows up later. As hospital systems and healthcare enterprises face growing pressure to justify technology spend, platforms that can quantify ROI directly are becoming a distinct and fundable category on their own.
The round reflects a broader shift visible across June and early July's funding activity in the Southeast US, where healthtech, cybersecurity, and fintech startups have continued attracting investor attention even as the wider venture market stays selective.
For founders building healthcare-adjacent AI products, Optura's raise underlines a pattern worth noting: investors are rewarding companies that build measurement and accountability directly into their product, rather than leaving customers to work out AI's value on their own.